http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1192383-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e290c2c98c6d069b585f00e72fe5806 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 1997-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e90a7932d6ebff2723221fb0ce4f8f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9241de3c3e2d4c00bc0876b95364be0 |
| publicationDate | 1999-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H1192383-A |
| titleOfInvention | Composition for treating corneal epithelial defect and use thereof |
| abstract | (57) [Problem] To provide a therapeutic composition for corneal epithelial defect. The present inventors have discovered that hydrocortisone, one of the glucocorticosteroids, induces cell division of rabbit-derived corneal epithelial cells. Based on this finding, a solution obtained by diluting methylprednisolone, a different glucocorticosteroid, with physiological saline was applied to patients with corneal epithelial deficiency, and the therapeutic effect was examined. In addition, in this solution, it carried out on the conditions which do not contain a preservative (preservative). As a result of instillation of this solution, 6 out of 6 cases were able to treat the corneal epithelial defect. |
| priorityDate | 1997-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.